98%
921
2 minutes
20
Introduction: The standard treatment for gastroesophageal reflux disease (GERD) is proton pump inhibitors (PPIs). In selected cases, Nissen fundoplication is offered as a surgical treatment option, but alternative endoscopic and minimally invasive surgical alternatives are emerging. RefluxStop is a new technology for the treatment of GERD.
Research Design And Methods: A cost-effectiveness analysis of RefluxStop in comparison to PPI therapy and Nissen fundoplication in the Swedish healthcare setting was conducted using a Markov model and available comprehensive population and clinical trial-based long-term data. Benefits were measured in quality-adjusted life-years (QALYs). Uncertainty was determined by deterministic and probabilistic sensitivity analyses.
Results: The base case incremental cost-effectiveness ratios (ICERs) for RefluxStop in comparison to PPIs and Nissen fundoplications were SEK 48,152 (€ 4,531) and SEK 62,966 (€ 5,925) per QALY gained, respectively. At a cost-effectiveness threshold of SEK 500,000 per QALY gained, RefluxStop has a high likelihood of being cost-effective, with probabilities of 96% and 100% against Nissen fundoplication and PPIs, respectively. The results of the model remained robust with sensitivity analysis.
Conclusions: RefluxStop may offer a highly cost-effective long-term treatment alternative for chronic GERD patients over lifelong PPI therapy, but also in comparison with laparoscopic Nissen fundoplication.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14737167.2024.2417774 | DOI Listing |
Diabetes Obes Metab
September 2025
Department of Minimally Invasive Surgery, Hernias and Abdominal Wall Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Gastroesophageal Reflux Disease and Bariatric Metabolic Surgery, Research Institute of General and Minimally Invasive Surgery, Ur
Aims: This randomised controlled trial compared the efficacy of modified laparoscopic sleeve gastrectomy with fundoplication (LSGFD) versus standard laparoscopic sleeve gastrectomy (LSG) in achieving weight loss and alleviating gastroesophageal reflux disease (GERD) in patients with obesity.
Materials And Methods: Eighty patients with obesity (body mass index [BMI] ≥27.5 kg/m with comorbidities or ≥32.
Ann Thorac Surg
September 2025
Department of Surgery, Section of Thoracic Surgery, University of Arizona, 1625 North Campbell Avenue Tucson, Arizona, 85718. Electronic address:
Cureus
August 2025
Gastroenterology, Methodist Health System, Dallas, USA.
Achalasia is a motility disorder of the esophagogastric junction outflow, characterized by impaired lower esophageal sphincter (LES) relaxation and loss of normal peristalsis of the esophageal smooth muscle. The common clinical manifestations of achalasia include dysphagia of both solids and liquids, regurgitation of undigested food and saliva, and chest pain. It shares symptoms with gastroesophageal reflux disease (GERD), such as a retrosternal burning sensation and dysphagia, which can delay the diagnosis.
View Article and Find Full Text PDFActa Paediatr
September 2025
Institute of Systems Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Aims: Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, pulmonary hypertension and high mortality. Three decades experience from a UK centre is reported.
Methods: Medical records of CDH newborns between February 1990 and November 2021 and attending a multidisciplinary clinic were examined.
J Gastrointest Surg
August 2025
Division of Digestive Surgery (Esophageal and Gastric Surgery Division), Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kawaramachi-hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Background: Lower mediastinal esophagogastrostomy after proximal gastrectomy with lower esophagectomy for esophagogastric junction (EGJ) cancer remains technically demanding due to the high risk of anastomotic leakage and reflux. We developed a novel reconstruction technique, the short middle overlap anastomosis reinforced with Toupet-like fundoplication (SMART) method, to address these challenges.
Methods: From March 2017 to April 2025, 40 patients underwent radical surgery for EGJ cancer at our institution.